Popular Articles
Burdock Root

Burgess Accepts President Obama's Offer To Meet And Discuss Health Reform Bill
Congressman Michael C. Burgess, M.D. (R-Texas) sent a letter to President Obama yesterday accepting his invitation to "come over to the White House and go over line-by-line" the health care reform plan the President is pushing.
generic viagra online
Somaxon Resubmits New Drug Application For Silenor(R) (Doxepin) For The Treatment Of Insomnia
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Silenor® (doxepin) for the treatment of insomnia.
News of the day
Nearly 1.4 Million Tennesseans Are In Families That Will Spend More Than 10 Percent Of Their Income On Health Care In 2009
A report released by the consumer health organization Families USA spotlights a growing crisis among insured families, as rising health care costs devour a growing portion of their pre-tax income.
Endocrinology

New England Cord Blood Bank Installs Automated Cord Blood Processing Line

New England Cord Blood Bank, Inc. (NECBB), a global cord blood processing and storage facility, announced today that it will be implementing an automated blood processing system at the company"s Newton facility. The AutoXpress™ System (AXP), developed by ThermoGenesis Corp. and distributed by GE Healthcare, is a state-of-the-art, fully closed and sterile system that will provide automated cell separation and processing for cord blood samples, ensuring quality and consistency in cord blood processing while maximizing the yield of valuable stem cells from the cord blood. "Families entrust us with a precious gift for safekeeping," said John Rizza, President of the New England Cryogenics Center, Inc., the parent company of NECBB. "We are pleased to be able to offer our clients the added level of confidence and security that this advanced technology provides." AXP is fast, precise, and - according to data provided by New York Blood Center - can harvest greater than 97% of the mononucleated cell (MNC) population, which is rich in stem cells, without the use of additives. By automating the process, AXP minimizes the risk of contamination and ensures predictable and reliable results. Further, the system captures essential data for quality assurance and compliance with current good tissue practices. NECBB will begin processing samples with AXP in August. In addition to the automation, NECBB will continue to operate their manual system, which will allow for processing of samples too small for the automated system. NECBB currently accepts and processes private cord blood samples from parents looking to preserve stem cells from their newborn"s cord blood, which are then available for the family to use at any time. Implementation of the automated system also brings NECBB one step closer to accreditation as a public cord blood bank. "We are excited at the possibilities afforded us by installing the AXP system," added Rizza. "It is our goal to ensure that we provide families with all possible options, and with the information they need to make the choice that fits best for them." Cord blood banking, both simple and secure, is a life-giving opportunity that happens at the time of birth. It offers a powerful medical re in fighting both chronic and acute diseases that may develop within the child or a family member. Currently, cord blood is used to treat over 80 diseases including sickle cell anemia, leukemia and various cancers. New England Cord Blood Bank


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):